Wolverine Asset Management »

Coherus Biosciences shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Coherus Biosciences (CHRS) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Coherus Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Coherus Biosciences held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coherus Biosciences by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.6k 2.6k 3.33
2023-09-30 $52k 14k 3.74
2023-06-30 $38k 8.8k 4.27
2023-03-31 $684 100 6.84
2022-12-31 $72k 9.1k 7.92
2021-09-30 $22k 1.4k 15.71
2021-06-30 $19k 1.4k 13.57

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Coherus Biosciences

Vanguard Group
Barclays
Kohlberg Kravis Roberts & Co
Millennium Management
Citadel Advisors
Bank of America Corporation
CAM Group Holding A/S
Jacobs Levy Equity Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Peregrine Capital Management
Goldman Sachs Group
CM Management
Charles Schwab Investment Management
Fifth Lane Capital

View all funds holding Coherus Biosciences